Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

Nippon Chemiphar discontinues development of cathepsin K inhibitor licensed to Velcura

Aug. 1, 2011

RaQualia grants rights for serotonin 5-HT4 partial agonist to CJ CheilJedang

Aug. 1, 2011

Invaron Pharmaceuticals obtains license for Striant

Aug. 1, 2011

Ribovax out-licenses SEBVI antibody technology

July 29, 2011

Immunotec and Nova Southeastern University to test autism treatment

July 29, 2011

Ironwood Pharmaceuticals licenses Depomed's gastric retentive drug delivery technology

July 29, 2011

SkyePharma licenses asthma treatment candidate to Sanofi in Latin America

July 28, 2011

Trius Therapeutics and Bayer sign torezolid deal

July 28, 2011

Dyax licenses antibody phage display libraries to Kadmon

July 28, 2011

BioWa and arGEN-X enter license agreement for Potelligent technology

July 28, 2011

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...